Bill Text — Dec 17, 2013
This bill’s text is now available.
Apr 17, 2007
110th Congress, 2007–2009
This bill was introduced on April 17, 2007, in a previous session of Congress, but was not enacted.
Representative for Illinois's 1st congressional district
Read Text »
Last Updated: Apr 17, 2007
Length: 7 pages
To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and for other purposes.
Legislative action may be ocurring on one of these bills in lieu of or in parallel to action on this bill.
Referred to Committee
Last Action: Mar 25, 2009
The “H.R.” in “H.R. 1902” means this is a House of Representatives bill in the United States Congress. A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
The bill’s title was written by its sponsor.
The committee chair determines whether a bill will move past the committee stage.
There have been no votes related to this bill.
Search for similar bills.
Click a format for a citation suggestion:
Civic Impulse. (2015). H.R. 1902 — 110th Congress: Protecting Consumer Access to Generic Drugs Act of 2007. Retrieved from https://www.govtrack.us/congress/bills/110/hr1902
“H.R. 1902 — 110th Congress: Protecting Consumer Access to Generic Drugs Act of 2007.” www.GovTrack.us. 2007. July 4, 2015 <https://www.govtrack.us/congress/bills/110/hr1902>
|title=H.R. 1902 (110th)
|accessdate=July 4, 2015
|author=110th Congress (2007)
|date=April 17, 2007
|quote=Protecting Consumer Access to Generic Drugs Act of 2007